BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16891648)

  • 1. TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats.
    Yamahana J; Wada T; Furuichi K; Sakai N; Yokoyama H; Kaneko S
    Nephrol Dial Transplant; 2006 Oct; 21(10):2736-44. PubMed ID: 16891648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
    Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
    Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
    Phoon RK; Kitching AR; Jones LK; Holdsworth SR
    Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
    Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
    Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
    Aki K; Shimizu A; Masuda Y; Kuwahara N; Arai T; Ishikawa A; Fujita E; Mii A; Natori Y; Fukunaga Y; Fukuda Y
    Am J Physiol Renal Physiol; 2010 Apr; 298(4):F870-82. PubMed ID: 20071465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D; Nazneen A; Taguchi T; Razzaque MS
    Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats.
    Takabatake Y; Li XK; Mizui M; Miyasato K; Matsui I; Kawada N; Imai E; Hünig T; Takahara S; Wada T; Furuichi K; Rakugi H; Isaka Y
    Mol Med; 2011; 17(7-8):686-96. PubMed ID: 21487638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar-Kyoto rats.
    Higuchi N; Maruyama H; Kuroda T; Kameda S; Iino N; Kawachi H; Nishikawa Y; Hanawa H; Tahara H; Miyazaki J; Gejyo F
    Gene Ther; 2003 Aug; 10(16):1297-310. PubMed ID: 12883526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
    Cook HT; Khan SB; Allen A; Bhangal G; Smith J; Lobb RR; Pusey CD
    Am J Pathol; 2002 Oct; 161(4):1265-72. PubMed ID: 12368200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
    Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of CD8-positive lymphocytes in glomerular expression of ICAM-1 and cytokines in crescentic glomerulonephritis of WKY rats.
    Fujinaka H; Yamamoto T; Feng L; Kawasaki K; Yaoita E; Hirose S; Goto S; Wilson CB; Uchiyama M; Kihara I
    J Immunol; 1997 May; 158(10):4978-83. PubMed ID: 9144517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
    Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
    J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
    Tang Z; Zhou H; Yao X; Hu W; Leishi L
    Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis.
    Han Y; Ma FY; Tesch GH; Manthey CL; Nikolic-Paterson DJ
    Am J Physiol Renal Physiol; 2013 Apr; 304(8):F1043-53. PubMed ID: 23408165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats.
    Kovalenko P; Fujinaka H; Yoshida Y; Kawamura H; Qu Z; El-Shemi AG; Li H; Matsuki A; Bilim V; Yaoita E; Abo T; Uchiyama M; Yamamoto T
    Int Immunol; 2004 May; 16(5):625-34. PubMed ID: 15096492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease.
    Mu W; Ouyang X; Agarwal A; Zhang L; Long DA; Cruz PE; Roncal CA; Glushakova OY; Chiodo VA; Atkinson MA; Hauswirth WW; Flotte TR; Rodriguez-Iturbe B; Johnson RJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3651-60. PubMed ID: 16251240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rottlerin inhibits human T cell responses.
    Springael C; Thomas S; Rahmouni S; Vandamme A; Goldman M; Willems F; Vosters O
    Biochem Pharmacol; 2007 Feb; 73(4):515-25. PubMed ID: 17141738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
    Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
    Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
    Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
    Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suppressive effects of GTW treatment on infiltration of inflammatory cell in glomeruli in anti-Thy1.1 glomerulonephritis].
    Wan Y; Sun W; Che X; Yang H; Ge M; Dai W; Shimizu F
    Zhongguo Zhong Yao Za Zhi; 2009 Jan; 34(1):72-7. PubMed ID: 19382456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.